Viewing Study NCT03241550


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-02-23 @ 6:24 AM
Study NCT ID: NCT03241550
Status: COMPLETED
Last Update Posted: 2024-11-19
First Post: 2017-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematological Malignancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None invasive fungal disease View
None Cresemba® View
None Hematological malignancy View
None isavuconazonium sulfate View
None ASP9766 View
None isavuconazole View
None pediatric population View